An observational study in Spatiotemporal Patterns, sponsored by National Institute of Neurological Disorders and Stroke (NINDS). Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-02.
Sponsored by National Institute of Neurological Disorders and Stroke (NINDS) · Observational
This study of healthy normal volunteers will examine the brain networks involved in people's sense that they control their own movements (sense of agency). Although almost everyone has a sense of agency, some patients (for example, patients with schizophrenia, alien limb phenomena, and others) have movements they think are not under their control. This study will use electroencephalography (EEG) to determine how the normal brain produces the sense of agency. This information will provide a first step in understanding patients with an impaired sense of agency.
Healthy, right-handed men and women 18 years of age and older may be eligible for this study. Candidates are screened with a medical history and neurological examination.
Participants are fitted with a cyberglove device (a lightweight glove with flexible sensors that measure the position and movement of the fingers and wrist) on their right hand. The glove is used to transform the subject's hand and finger motions into real-time digital joint-angle information. Subjects slowly open and close their hand while watching an artificial hand projected on a monitor. They continue practicing the exercise until they are comfortable with the cyberglove and have the sense that the artificial hand is a mirror representation of their own hand, accurately reflecting their hand's movements.
After practicing with the cyberglove, subjects have a functional EEG. For this test, electrodes are placed on the scalp, and brain waves are recorded while the subject opens and closes his or her hand or just watches the computer monitor. The EEG recording takes about 60 minutes.
...
Objective
The purpose of this study is to investigate spatiotemporal patterns of brain networks involved in the sense of agency using high-resolution electroencephalography (EEG).
Study Population
We intend to use 20 right-hand dominant, adult healthy subjects.
Design
The sense of agency (SA) will be modulated using a visual task-based stimulus asking subjects to manipulate the position of an artificial hand projected onto a display. Subjects will use their own right hand to make slow opening/closing movements randomly which will be represented visually with the aid of a Cyberglove. During a behavioral training phase, subjects will practice using the apparatus. The level of control will be randomly changed to one of five states: 100%, 75%, 50%, 25%, 0% control. For secondary analysis, subjects will be asked to report the percentage of control they subjectively feel over the displayed hand. After subjects are comfortable with the apparatus and endorse SA over the displayed hand, they will undergo EEG.
The experimental phase will have five sets of 10 minute recording sessions where the subject is instructed to slowly open and close their hand randomly. The level of control will be changed pseudo-randomly throughout the recording sessions. A control contrast consisting of the subject observing a moving hand will also be integrated into the blocks. An additional control contrast involving the subject moving their hand without visual feedback will also be included. These contrasts will serve in the analysis phase to help eliminate electrophysiological activity related to visual-motor feedback.
A Magnetic Resonance Imaging (MRI) scan of brain will be performed to co-register this EEG data with the anatomical structure. We will integrate physiological (EEG) and anatomical (MRI) data to characterize the regionalization of the task-related brain EEG activity.
Outcome Measures
The primary outcome of this study is the effective connectivity of brain in response to a loss of SA. For this purpose, we will measure the difference of EEG power spectral analysis as well as coherence between 0% and 100 % control. In a secondary analysis, we will investigate the correlation of the EEG measurements with the percent of actual control, and also utilize the individual subject perceptions of percent control during the behavioral training phase as the regressors for activation rather than the objective control settings.
National Institute of Neurological Disorders and Stroke (NINDS) is the lead sponsor of 592 studies on the registry; 56 are open to participants now.
Of its 18 completed or terminated interventional studies of FDA-regulated products, 8 (44%) have results posted.
Counted across the registry records on this site, refreshed daily.
Subjects age 18 and older
Subjects must be right-hand dominant (Edinburgh Handedness Quotient greater than 60)
Subjects willing to abstain from caffeine or alcohol for 48 hours prior to the EEG study
EXCLUSION CRITERIA:
Subjects with any abnormal findings on neurological exam
Subjects with any history of brain tumor, stroke, head trauma or a vascular malformation as obtained by history or from imaging studies
Subjects with any history of a severe medical condition, such as cardiovascular disease, which would prevent them from sitting for up to 120 minutes
Subjects without the capacity to give informed consent
Subjects with other restrictions which prevent them from undergoing EEG recordings for up to 60 minutes
Subjects who are taking neuroleptic medications
Subjects are not eligible for Magnetic Resonance Imaging (MRI) scan, if the subjects have pacemakers, intracardiac line, implanted metallic pump, neural stimulator, or a metallic object inside the skull, metal braces, cochlear devices, surgical clips and other metal/magnetic implants; are afraid of being in small spaces; are pregnant
This study is completed, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Neurological Disorders and Stroke (NINDS)